Loading...

Ralph W deVere White, MD

Title(s)Professor, Urology
SchoolUniversity of California, Davis
Address4501 X St
CA 95817
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice. Int J Mol Sci. 2019 Oct 09; 20(20). Martin KA, Hum NR, Sebastian A, He W, Siddiqui S, Ghosh PM, Pan CX, de Vere White R, Loots GG. PMID: 31600961.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Correlation of Platinum Cytotoxicity to Drug-DNA Adduct Levels in a Breast Cancer Cell Line Panel. Chem Res Toxicol. 2018 12 17; 31(12):1293-1304. Wang S, Scharadin TM, Zimmermann M, Malfatti MA, Turteltaub KW, de Vere White R, Pan CX, Henderson PT. PMID: 30381944.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    3. Immediate intravesical chemotherapy for low-grade bladder tumors in California: An underutilized practice and its impact on recurrence. Urol Oncol. 2018 11; 36(11):498.e1-498.e7. Yap SA, Brunson A, Pugashetti N, M P H RDC, Keegan THM, deVere White R, Wun T. PMID: 30236855.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. New Insights into Ejaculatory Frequency and Prostate Cancer Risk: Association, Causation, or What Do We Have to Lose? Eur Urol. 2018 11; 74(5):549-550. Dall'Era MA, De Vere White RW. PMID: 30177292.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. The Promise and Disappointment of Neoadjuvant Chemotherapy and Transurethral Resection for Muscle Invasive Bladder Cancer: Updated Results and Long-Term Followup. Urology Practice. 2018 Jul 1; 5(4):305-310. Stanley A. Yap, Neil Pugashetti, Thenappan Chandrasekar, Marc A. Dall’Era, Christopher P. Evans, Primo N. Lara, Ralph W. deVere White. .
      View in: Publisher Site   Mentions:
    6. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015. Eur Urol Focus. 2019 11; 5(6):1014-1021. Dall'Era MA, deVere-White R, Rodriguez D, Cress R. PMID: 29735368.
      View in: PubMed   Mentions: 2     Fields:    
    7. Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy. J Pharmacol Exp Ther. 2018 06; 365(3):494-506. Ho PY, Duan Z, Batra N, Jilek JL, Tu MJ, Qiu JX, Hu Z, Wun T, Lara PN, DeVere White RW, Chen HW, Yu AM. PMID: 29602831.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    8. Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model. Nanomedicine. 2018 04; 14(3):789-799. Long Q, Lin TY, Huang Y, Li X, Ma AH, Zhang H, Carney R, Airhart S, Lam KS, deVere White RW, Pan CX, Li Y. PMID: 29317342.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    9. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. FASEB J. 2018 03; 32(3):1537-1549. Wang M, Yao LC, Cheng M, Cai D, Martinek J, Pan CX, Shi W, Ma AH, De Vere White RW, Airhart S, Liu ET, Banchereau J, Brehm MA, Greiner DL, Shultz LD, Palucka K, Keck JG. PMID: 29146734.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    10. COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther. 2018 02; 17(2):474-483. Wang F, Zhang H, Ma AH, Yu W, Zimmermann M, Yang J, Hwang SH, Zhu D, Lin TY, Malfatti M, Turteltaub KW, Henderson PT, Airhart S, Hammock BD, Yuan J, de Vere White RW, Pan CX. PMID: 29284644.
      View in: PubMed   Mentions:
    11. Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells. Sci Rep. 2017 09 25; 7(1):12277. Gheibi P, Zeng S, Son KJ, Vu T, Ma AH, Dall'Era MA, Yap SA, de Vere White RW, Pan CX, Revzin A. PMID: 28947782.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    12. The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer. Clin Cancer Res. 2017 Nov 01; 23(21):6580-6591. Zeng SX, Zhu Y, Ma AH, Yu W, Zhang H, Lin TY, Shi W, Tepper CG, Henderson PT, Airhart S, Guo JM, Xu CL, deVere White RW, Pan CX. PMID: 28808038.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    13. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene. 2017 11 16; 36(46):6359-6373. D'Abronzo LS, Bose S, Crapuchettes ME, Beggs RE, Vinall RL, Tepper CG, Siddiqui S, Mudryj M, Melgoza FU, Durbin-Johnson BP, deVere White RW, Ghosh PM. PMID: 28745319.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    14. A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancer. Int J Cancer. 2017 08 01; 141(3):604-613. Wang SS, Zimmermann M, Zhang H, Lin TY, Malfatti M, Haack K, Turteltaub KW, Cimino GD, de Vere White R, Pan CX, Henderson PT. PMID: 28437852.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models. Oncotarget. 2017 May 09; 8(19):30742-30755. Jian C, Tu MJ, Ho PY, Duan Z, Zhang Q, Qiu JX, DeVere White RW, Wun T, Lara PN, Lam KS, Yu AX, Yu AM. PMID: 28415566.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    16. Re: Management of Nonmuscle Invasive Bladder Cancer: A Comprehensive Analysis of Guidelines from the Unites States, Europe, and Asia. Eur Urol. 2017 04; 71(4):688. de Vere White R. PMID: 28073601.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice. Mol Cancer Ther. 2017 02; 16(2):376-387. Zimmermann M, Wang SS, Zhang H, Lin TY, Malfatti M, Haack K, Ognibene T, Yang H, Airhart S, Turteltaub KW, Cimino GD, Tepper CG, Drakaki A, Chamie K, de Vere White R, Pan CX, Henderson PT. PMID: 27903751.
      View in: PubMed   Mentions:
    18. Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact? Bladder Cancer. 2016 Oct 27; 2(4):441-448. Chandrasekar T, Pugashetti N, Durbin-Johnson B, Dall'Era MA, Evans CP, deVere White RW, Yap SA. PMID: 28035325.
      View in: PubMed   Mentions:
    19. Diagnostic Microdosing Approach to Study Gemcitabine Resistance. Chem Res Toxicol. 2016 11 21; 29(11):1843-1848. Scharadin TM, Zhang H, Zimmermann M, Wang S, Malfatti MA, Cimino GD, Turteltaub K, de Vere White R, Pan CX, Henderson PT. PMID: 27657672.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    20. Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer. Nanotechnology. 2016 Oct 21; 27(42):425103. Pan A, Zhang H, Li Y, Lin TY, Wang F, Lee J, Cheng M, Dall'Era M, Li T, deVere White R, Pan CX, Lam KS. PMID: 27640312.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    21. Perioperative Outcomes following Neoadjuvant Chemotherapy and Radical Cystectomy—Is There Room for Improvement?. Urology Practice. 2016 Sep 1; 3(5):364-370. Neil Pugashetti, Thenappan Chandrasekar, Robert Lurvey, Blythe Durbin-Johnson, Marc A. Dall'Era, Ralph W. deVere White, Christopher P. Evans, Stanley A. Yap. .
      View in: Publisher Site   Mentions:
    22. Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer. Biomaterials. 2016 10; 104:339-51. Lin TY, Li Y, Liu Q, Chen JL, Zhang H, Lac D, Zhang H, Ferrara KW, Wachsmann-Hogiu S, Li T, Airhart S, deVere White R, Lam KS, Pan CX. PMID: 27479049.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    23. Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry. J Urol. 2016 11; 196(5):1378-1382. Lara J, Brunson A, Keegan TH, Malogolowkin M, Pan CX, Yap S, deVere White R. PMID: 27208515.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer. Cancer. 2016 06 15; 122(12):1897-904. Chow H, Ghosh PM, deVere White R, Evans CP, Dall'Era MA, Yap SA, Li Y, Beckett LA, Lara PN, Pan CX. PMID: 27019001.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    25. Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy. Genes Cancer. 2016 Mar; 7(3-4):86-97. Vinall RL, Tepper CG, Ripoll AA, Gandour-Edwards RF, Durbin-Johnson BP, Yap SA, Ghosh PM, deVere White RW. PMID: 27382433.
      View in: PubMed   Mentions:
    26. Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer. PLoS One. 2016; 11(1):e0146256. Wang S, Zhang H, Scharadin TM, Zimmermann M, Hu B, Pan AW, Vinall R, Lin TY, Cimino G, Chain P, Vuyisich M, Gleasner C, Mcmurry K, Malfatti M, Turteltaub K, de Vere White R, Pan CX, Henderson PT. PMID: 26799320.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    27. miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src. Cancer Res. 2015 Dec 15; 75(24):5309-17. Shi XB, Ma AH, Xue L, Li M, Nguyen HG, Yang JC, Tepper CG, Gandour-Edwards R, Evans CP, Kung HJ, deVere White RW. PMID: 26573802.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    28. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. PLoS One. 2015; 10(8):e0134346. Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW. PMID: 26270481.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    29. Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization. J Pharmacol Exp Ther. 2015 Aug; 354(2):131-41. Wang WP, Ho PY, Chen QX, Addepalli B, Limbach PA, Li MM, Wu WJ, Jilek JL, Qiu JX, Zhang HJ, Li T, Wun T, White RD, Lam KS, Yu AM. PMID: 26022002.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    30. Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform. Clin Lung Cancer. 2015 May; 16(3):165-72. Gandara DR, Mack PC, Bult C, Li T, Lara PN, Riess JW, Astrow SH, Gandour-Edwards R, Cooke DT, Yoneda KY, Moore EH, Pan CX, Burich RA, David EA, Keck JG, Airhart S, Goodwin N, de Vere White RW, Liu ET. PMID: 25838158.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    31. The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence. J Urol. 2015 Jan; 193(1):19-29. Mooso BA, Vinall RL, Mudryj M, Yap SA, deVere White RW, Ghosh PM. PMID: 25158272.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    32. The role of microRNA in castration-resistant prostate cancer. Urol Oncol. 2014 Jul; 32(5):517-523. Thieu W, Tilki D, de Vere White R, Evans CP. PMID: 24935732.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    33. Toward a common therapeutic framework in castration-resistant prostate cancer: a model for urologic oncology and medical oncology interaction. Urol Oncol. 2014 May; 32(4):380-2. de Vere White R, Lara PN. PMID: 24316022.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Legends in urology. Can J Urol. 2014 Apr; 21(2):7176-8. White RW. PMID: 24775566.
      View in: PubMed   Mentions:    Fields:    
    35. Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model. Oncogene. 2014 Sep 04; 33(36):4521-30. Nguyen HG, Yang JC, Kung HJ, Shi XB, Tilki D, Lara PN, DeVere White RW, Gao AC, Evans CP. PMID: 24662833.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    36. No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period. Cancer. 2014 Mar 15; 120(6):818-23. Wu JN, Fish KM, Evans CP, Devere White RW, Dall'Era MA. PMID: 24258693.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    37. miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. Oncogene. 2014 May 08; 33(19):2495-503. Kao CJ, Martiniez A, Shi XB, Yang J, Evans CP, Dobi A, deVere White RW, Kung HJ. PMID: 23728339.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimalsCells
    38. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. PLoS One. 2013; 8(4):e61064. Amir S, Ma AH, Shi XB, Xue L, Kung HJ, Devere White RW. PMID: 23585871.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    39. Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer. Nanomedicine (Lond). 2013 Aug; 8(8):1239-51. Lin TY, Li YP, Zhang H, Luo J, Goodwin N, Gao T, White Rde V, Lam KS, Pan CX. PMID: 23199207.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    40. Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization. Endocr Relat Cancer. 2012 Dec; 19(6):759-77. Mooso BA, Vinall RL, Tepper CG, Savoy RM, Cheung JP, Singh S, Siddiqui S, Wang Y, Bedolla RG, Martinez A, Mudryj M, Kung HJ, Devere White RW, Ghosh PM. PMID: 22993077.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    41. Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene. 2013 Aug 29; 32(35):4130-8. Shi XB, Xue L, Ma AH, Tepper CG, Gandour-Edwards R, Kung HJ, deVere White RW. PMID: 23069658.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    42. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma. Am J Vet Res. 2012 Oct; 73(10):1626-33. Vinall RL, Kent MS, deVere White RW. PMID: 23013190.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    43. Functional p53 determines docetaxel sensitivity in prostate cancer cells. Prostate. 2013 Mar; 73(4):418-27. Liu C, Zhu Y, Lou W, Nadiminty N, Chen X, Zhou Q, Shi XB, deVere White RW, Gao AC. PMID: 22996738.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    44. Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. Int J Nanomedicine. 2012; 7:2793-804. Lin TY, Zhang H, Luo J, Li Y, Gao T, Lara PN, de Vere White R, Lam KS, Pan CX. PMID: 22745542.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    45. Human ESC self-renewal promoting microRNAs induce epithelial-mesenchymal transition in hepatocytes by controlling the PTEN and TGFß tumor suppressor signaling pathways. Mol Cancer Res. 2012 Jul; 10(7):979-91. Jung CJ, Iyengar S, Blahnik KR, Jiang JX, Tahimic C, Torok NJ, de vere White RW, Farnham PJ, Zern M. PMID: 22622027.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    46. Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression. Dis Model Mech. 2012 Nov; 5(6):914-20. Vinall RL, Chen JQ, Hubbard NE, Sulaimon SS, Shen MM, Devere White RW, Borowsky AD. PMID: 22563073.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    47. MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth. PLoS One. 2012; 7(3):e32832. Nadiminty N, Tummala R, Lou W, Zhu Y, Shi XB, Zou JX, Chen H, Zhang J, Chen X, Luo J, deVere White RW, Kung HJ, Evans CP, Gao AC. PMID: 22479342.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimalsCells
    48. In vivo testing of a prototype system providing simultaneous white light and near infrared autofluorescence image acquisition for detection of bladder cancer. J Biomed Opt. 2012 Mar; 17(3):036011. Jacobson MC, deVere White R, Demos SG. PMID: 22502569.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    49. Stem-like cells in bladder cancer cell lines with differential sensitivity to cisplatin. Anticancer Res. 2012 Mar; 32(3):733-8. Falso MJ, Buchholz BA, White RW. PMID: 22399585.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    50. Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109. Urology. 2012 Mar; 79(3):633-7. Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll PR, Canby-Hagino ED, deVere White R, Hemstreet GP, Crawford ED, Thompson IM, Klein EA. PMID: 22386416.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    51. MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status. Int J Cancer. 2012 Jun 01; 130(11):2526-38. Vinall RL, Ripoll AZ, Wang S, Pan CX, deVere White RW. PMID: 21702042.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    52. MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells. J Biol Chem. 2012 Jan 06; 287(2):1527-37. Nadiminty N, Tummala R, Lou W, Zhu Y, Zhang J, Chen X, eVere White RW, Kung HJ, Evans CP, Gao AC. PMID: 22128178.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCells
    53. Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples. Adv Virol. 2011; 2011:272193. Kearney MF, Lee K, Bagni RK, Wiegand A, Spindler J, Maldarelli F, Pinto PA, Linehan WM, Vocke CD, Delviks-Frankenberry KA, Devere White RW, Del Prete GQ, Mellors JW, Lifson JD, Kewalramani VN, Pathak VK, Coffin JM, Le Grice SF. PMID: 22312339.
      View in: PubMed   Mentions:
    54. Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3. Clin Cancer Res. 2011 Oct 01; 17(19):6218-28. Chen L, Mooso BA, Jathal MK, Madhav A, Johnson SD, van Spyk E, Mikhailova M, Zierenberg-Ripoll A, Xue L, Vinall RL, deVere White RW, Ghosh PM. PMID: 21844010.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    55. Dual blockade of PKA and NF-?B inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis. Horm Cancer. 2011 Aug; 2(4):224-38. Vinall RL, Mahaffey CM, Davis RR, Luo Z, Gandour-Edwards R, Ghosh PM, Tepper CG, de Vere White RW. PMID: 21789713.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    56. Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. Analyst. 2011 Sep 21; 136(18):3663-71. Hua S, An HJ, Ozcan S, Ro GS, Soares S, DeVere-White R, Lebrilla CB. PMID: 21776491.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    57. A model for rural oncology. J Oncol Pract. 2011 May; 7(3):168-71. Heifetz LJ, Christensen SD, Devere-White RW, Meyers FJ. PMID: 21886498.
      View in: PubMed   Mentions: 4     Fields:    
    58. Influence of short polyglutamine tracts and p160 coactivators on the transactivation of the androgen receptor. Cancer Biother Radiopharm. 2011 Apr; 26(2):191-201. Shi XB, Xue L, Shi D, deVere White RW. PMID: 21539451.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    59. Secondary malignancies among nonseminomatous germ cell tumor cancer survivors. Cancer. 2011 Sep 15; 117(18):4219-30. Chamie K, Kurzrock EA, Evans CP, Litwin MS, Koppie TM, Wootton-Gorges SL, Boone JM, Lara PN, Devere White RW. PMID: 21412759.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    60. A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance. Int J Cancer. 2011 Sep 15; 129(6):1425-34. Henderson PT, Li T, He M, Zhang H, Malfatti M, Gandara D, Grimminger PP, Danenberg KD, Beckett L, de Vere White RW, Turteltaub KW, Pan CX. PMID: 21128223.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    61. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011 May; 59(5):671-81. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T. PMID: 21296484.
      View in: PubMed   Mentions: 176     Fields:    Translation:Humans
    62. Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand. Mol Cancer. 2011 Jan 27; 10(1):9. Lin TY, Zhang H, Wang S, Xie L, Li B, Rodriguez CO, de Vere White R, Pan CX. PMID: 21272294.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    63. Men of higher socioeconomic status have improved outcomes after radical prostatectomy for localized prostate cancer. Urology. 2010 Dec; 76(6):1409-13. Hellenthal NJ, Parikh-Patel A, Bauer K, Ralph W, deVere W, Koppie TM. PMID: 20888034.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    64. Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710). BJU Int. 2011 Sep; 108(5):693-9. Scosyrev E, Ely BW, Messing EM, Speights VO, Grossman HB, Wood DP, de Vere White RW, Vogelzang NJ, Trump DL, Natale RB, Tangen CM, Crawford ED, Thompson IM. PMID: 21105991.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    65. Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells. Chem Res Toxicol. 2010 Nov 15; 23(11):1653-5. Wang S, Zhang H, Malfatti M, de Vere White R, Lara PN, Turteltaub K, Henderson P, Pan CX. PMID: 21028869.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    66. Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach. Urol Oncol. 2012 Sep; 30(5):635-45. Zhang H, Aina OH, Lam KS, de Vere White R, Evans C, Henderson P, Lara PN, Wang X, Bassuk JA, Pan CX. PMID: 20888272.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    67. miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate. 2011 Apr; 71(5):538-49. Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, White RW. PMID: 20886540.
      View in: PubMed   Mentions: 80     Fields:    Translation:AnimalsCells
    68. Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate. 2011 May; 71(6):567-74. Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R, White Rde V. PMID: 20878953.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    69. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells. Cancer Res. 2010 Jul 15; 70(14):5994-6003. Chen L, Siddiqui S, Bose S, Mooso B, Asuncion A, Bedolla RG, Vinall R, Tepper CG, Gandour-Edwards R, Shi X, Lu XH, Siddiqui J, Chinnaiyan AM, Mehra R, Devere White RW, Carraway KL, Ghosh PM. PMID: 20587519.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    70. The dogmas of nutrition and cancer: time for a second (and maybe third) look. Ann N Y Acad Sci. 2010 Mar; 1190:118-25. de Vere White R, Hackman RM, Kugelmass J. PMID: 20388142.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Words of wisdom. Re: comparative effectiveness of minimally invasive vs open radical prostatectomy. Eur Urol. 2010 Feb; 57(2):355-6. de Vere White R. PMID: 20116768.
      View in: PubMed   Mentions:    Fields:    
    72. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer. Nutr Cancer. 2010; 62(8):1036-43. deVere White RW, Tsodikov A, Stapp EC, Soares SE, Fujii H, Hackman RM. PMID: 21058191.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    73. The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy. BJU Int. 2010 Feb; 105(4):485-8. Hellenthal NJ, Ramirez ML, Evans CP, Devere White RW. PMID: 19849694.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. Key concerns about the current state of bladder cancer: a position paper from the Bladder Cancer Think Tank, the Bladder Cancer Advocacy Network, and the Society of Urologic Oncology. Cancer. 2009 Sep 15; 115(18):4096-103. Lotan Y, Kamat AM, Porter MP, Robinson VL, Shore N, Jewett M, Schelhammer PF, deVere White R, Quale D, Lee CT. PMID: 19536899.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    75. MicroRNAs and their potential for translation in prostate cancer. Urol Oncol. 2009 May-Jun; 27(3):307-11. DeVere White RW, Vinall RL, Tepper CG, Shi XB. PMID: 19414119.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    76. A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219). J Urol. 2009 Jun; 181(6):2476-80; discussion 2480-1. deVere White RW, Lara PN, Goldman B, Tangen CM, Smith DC, Wood DP, Hussain MH, Crawford ED. PMID: 19371909.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    77. Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. J Urol. 2009 Jun; 181(6):2490-5. Hellenthal NJ, Ramírez ML, Evans CP, deVere White RW, Koppie TM. PMID: 19371902.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    78. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer. J Urol. 2009 May; 181(5):1994-7. deVere White RW, Katz MH, Steinberg GD. PMID: 19286209.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    79. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res. 2009 Feb 01; 15(3):788-96. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, de Vere White RW, Ghosh PM. PMID: 19188148.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    80. Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma. J Urol. 2009 Mar; 181(3):1013-8; discussion 1018-9. Hellenthal NJ, Chamie K, Ramirez ML, deVere White RW. PMID: 19150554.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    81. Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data. Bioinformatics. 2009 Jan 15; 25(2):251-7. Barkauskas DA, An HJ, Kronewitter SR, de Leoz ML, Chew HK, de Vere White RW, Leiserowitz GS, Miyamoto S, Lebrilla CB, Rocke DM. PMID: 19073586.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    82. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells. Prostate. 2008 Dec 01; 68(16):1816-26. Shi XB, Xue L, Zou JX, Gandour-Edwards R, Chen H, deVere White RW. PMID: 18780293.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    83. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2008 Nov 01; 113(9):2464-70. Chamie K, DeVere White RW, Lee D, Ok JH, Ellison LM. PMID: 18666213.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    84. The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. Am J Transplant. 2008 Dec; 8(12):2668-73. Chamie K, Ghosh PM, Koppie TM, Romero V, Troppmann C, deVere White RW. PMID: 18853950.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    85. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival. Oncogene. 2008 Nov 27; 27(56):7106-17. Wang Y, Mikhailova M, Bose S, Pan CX, deVere White RW, Ghosh PM. PMID: 18776922.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    86. MicroRNAs and prostate cancer. J Cell Mol Med. 2008 Sep-Oct; 12(5A):1456-65. Shi XB, Tepper CG, White RW. PMID: 18624768.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    87. Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines. BJU Int. 2008 Nov; 102(10):1458-66. Burich RA, Holland WS, Vinall RL, Tepper C, White RW, Mack PC. PMID: 18565171.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    88. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells. Mol Cancer Res. 2008 May; 6(5):808-18. Devlin HL, Mack PC, Burich RA, Gumerlock PH, Kung HJ, Mudryj M, deVere White RW. PMID: 18505925.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    89. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int. 2008 Aug; 102(3):284-90. Chamie K, Hu B, Devere White RW, Ellison LM. PMID: 18410437.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    90. Current applications for prostate-specific antigen doubling time. Eur Urol. 2008 Aug; 54(2):291-300. Ramírez ML, Nelson EC, Devere White RW, Lara PN, Evans CP. PMID: 18439749.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    91. Cancerous miRNAs and their regulation. . 2008 Jun 01; 7(11):1529-38. Shi XB, Tepper CG, deVere White RW. PMID: 18469525.
      View in: PubMed   Mentions:
    92. Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines. Dis Markers. 2008; 25(4-5):243-58. de Leoz ML, An HJ, Kronewitter S, Kim J, Beecroft S, Vinall R, Miyamoto S, de Vere White R, Lam KS, Lebrilla C. PMID: 19126968.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    93. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci U S A. 2007 Dec 11; 104(50):19983-8. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ, deVere White RW. PMID: 18056640.
      View in: PubMed   Mentions: 197     Fields:    Translation:HumansCells
    94. Characterization of oxaliplatin-DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations. Chem Res Toxicol. 2007 Dec; 20(12):1745-51. Hah SS, Sumbad RA, de Vere White RW, Turteltaub KW, Henderson PT. PMID: 18001055.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    95. Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis. Clin Cancer Res. 2007 Oct 15; 13(20):6204-16. Vinall RL, Hwa K, Ghosh P, Pan CX, Lara PN, de Vere White RW. PMID: 17947488.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    96. Novel p53/p130 axis in bladder tumors. Urology. 2007 Sep; 70(3):608-12. Mudryj M, Reay E, Beckett L, Dandekar S, deVere White R, Gandour-Edwards R. PMID: 17905135.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    97. Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway. Oncogene. 2008 Jan 17; 27(4):499-505. Liu S, Vinall RL, Tepper C, Shi XB, Xue LR, Ma AH, Wang LY, Fitzgerald LD, Wu Z, Gandour-Edwards R, deVere White RW, Kung HJ. PMID: 17653089.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    98. Finasteride for chemoprevention of prostate cancer: why has it not been embraced? J Clin Oncol. 2007 Jul 20; 25(21):2999-3000. de Vere White RW. PMID: 17634478.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    99. Cost-benefit and outcome analysis: effect of prostate biopsy undergrading. Urology. 2007 Jun; 69(6):1152-6. Cambio AJ, Ellison LM, Chamie K, deVere White RW, Evans CP. PMID: 17572205.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    100. The oncogenic potential of a prostate cancer-derived androgen receptor mutant. Prostate. 2007 May 01; 67(6):591-602. Shi XB, Xue L, Tepper CG, Gandour-Edwards R, Ghosh P, Kung HJ, DeVere White RW. PMID: 17262801.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    101. Inhibition of Akt pathways in the treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2007; 10(4):331-9. Nelson EC, Evans CP, Mack PC, Devere-White RW, Lara PN. PMID: 17471291.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    102. A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells. Oncogene. 2007 Sep 06; 26(41):6061-70. Wang Y, Kreisberg JI, Bedolla RG, Mikhailova M, deVere White RW, Ghosh PM. PMID: 17420725.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    103. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Prostate. 2007 Apr 01; 67(5):521-35. Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. PMID: 17252539.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    104. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1. J Cell Biol. 2007 Jan 01; 176(1):43-9. Liao YC, Si L, deVere White RW, Lo SH. PMID: 17190795.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimalsCells
    105. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. Prostate. 2006 Oct 01; 66(14):1474-86. Zou JX, Zhong Z, Shi XB, Tepper CG, deVere White RW, Kung HJ, Chen H. PMID: 16921507.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    106. Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group Study. Oncol Rep. 2006 Oct; 16(4):807-10. Grossman HB, Tangen CM, Cordon-Cardo C, Cote R, Waldman FM, De Vere White RW, Karnad AB, Glode M, Crawford ED. PMID: 16969498.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    107. Accrual issues in genitourinary cancer clinical trials. Urol Oncol. 2006 Sep-Oct; 24(5):379-83. Lara PN, de Vere White R. PMID: 16962485.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    108. Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells. Cancer Res. 2006 Sep 01; 66(17):8439-47. Ma AH, Xia L, Desai SJ, Boucher DL, Guan Y, Shih HM, Shi XB, deVere White RW, Chen HW, Tepper CG, Kung HJ. PMID: 16951154.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    109. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia. 2006 Sep; 8(9):708-15. Borowsky AD, Dingley KH, Ubick E, Turteltaub KW, Cardiff RD, Devere-White R. PMID: 16984728.
      View in: PubMed   Mentions: 21     Fields:    Translation:Animals
    110. Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules. Int J Oncol. 2006 Jul; 29(1):49-55. Burke PA, Gregg JP, Bakhtiar B, Beckett LA, Denardo GL, Albrecht H, De Vere White RW, De Nardo SJ. PMID: 16773184.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    111. Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry. Chem Res Toxicol. 2006 May; 19(5):622-6. Hah SS, Stivers KM, de Vere White RW, Henderson PT. PMID: 16696564.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    112. Transurethral resection of superficial bladder cancer using 5-aminolevulinic acid: are there any long-term benefits? Nat Clin Pract Urol. 2006 May; 3(5):254-5. Devere White RW. PMID: 16691236.
      View in: PubMed   Mentions:    Fields:    
    113. The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7. Oncogene. 2006 Mar 30; 25(14):2082-93. Vinall RL, Tepper CG, Shi XB, Xue LA, Gandour-Edwards R, de Vere White RW. PMID: 16434975.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    114. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer. Cancer Res. 2006 Jan 01; 66(1):175-83. You Z, Shi XB, DuRaine G, Haudenschild D, Tepper CG, Lo SH, Gandour-Edwards R, de Vere White RW, Reddi AH. PMID: 16397230.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    115. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells. Prostate. 2005 Dec 01; 65(4):375-89. Tepper CG, Gregg JP, Shi XB, Vinall RL, Baron CA, Ryan PE, Desprez PY, Kung HJ, deVere White RW. PMID: 16037992.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    116. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med. 2005 Jul; 2(4):532-40; discussion 540-2. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. PMID: 16422848.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCTClinical Trials
    117. Secondary transitional cell carcinoma and nitrogen mustard treatment. Urology. 2005 Jun; 65(6):1226-7. DeLair SM, White RW, Kurzrock EA. PMID: 15922437.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    118. The androgen receptor and mechanisms for androgen independence in prostate cancer. Cancer Invest. 2005; 23(6):520-8. Javidan J, Deitch AD, Shi XB, de Vere White RW. PMID: 16203660.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    119. Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status. Cancer Res. 2005 Jan 01; 65(1):54-65. Wetherill YB, Fisher NL, Staubach A, Danielsen M, de Vere White RW, Knudsen KE. PMID: 15665279.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    120. A modified yeast assay used on archival samples of localized prostate cancer tissue improves the detection of p53 abnormalities and increases their predictive value. BJU Int. 2004 Nov; 94(7):996-1002. Shi XB, Gandour-Edwards R, Beckett LA, Deitch AD, de Vere White RW. PMID: 15541116.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    121. Analysis of treatment for small cell cancer of the bladder and report of three cases. Urology. 2004 Sep; 64(3):494-8. Karpman E, Goldberg Z, Saffarian A, Gandour-Edwards R, Ellison LM, deVere White RW. PMID: 15351578.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    122. Molecular alterations associated with LNCaP cell progression to androgen independence. Prostate. 2004 Aug 01; 60(3):257-71. Shi XB, Ma AH, Tepper CG, Xia L, Gregg JP, Gandour-Edwards R, Mack PC, Kung HJ, deVere White RW. PMID: 15176055.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    123. Spectroscopic detection of bladder cancer using near-infrared imaging techniques. J Biomed Opt. 2004 Jul-Aug; 9(4):767-71. Demos SG, Gandour-Edwards R, Ramsamooj R, deVere White R. PMID: 15250764.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    124. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004 Jul 15; 22(14):2781-9. Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF, Crawford ED. PMID: 15199091.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    125. Near-infrared autofluorescence imaging for detection of cancer. J Biomed Opt. 2004 May-Jun; 9(3):587-92. Demos SG, Gandour-Edwards R, Ramsamooj R, White Rd. PMID: 15189097.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    126. Canine prostatic intraepithelial neoplasia: is the comparative model relevant? Prostate. 2004 Feb 15; 58(3):314-7. Madewell BR, Gandour-Edwards R, DeVere White RW. PMID: 14743472.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    127. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer. Urology. 2004 Feb; 63(2):259-63. deVere White RW, Hackman RM, Soares SE, Beckett LA, Li Y, Sun B. PMID: 14972467.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCTClinical Trials
    128. Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2004; 7(4):321-6. Gandour-Edwards R, Mack PC, Devere-White RW, Gumerlock PH. PMID: 15314639.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    129. The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion. BJU Int. 2004 Jan; 93(1):143-50. Wu X, Obata T, Khan Q, Highshaw RA, De Vere White R, Sweeney C. PMID: 14678387.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    130. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003 Aug 28; 349(9):859-66. Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP, Raghavan D, Crawford ED. PMID: 12944571.
      View in: PubMed   Mentions: 490     Fields:    Translation:HumansCTClinical Trials
    131. Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53. Cancer Res. 2003 May 01; 63(9):2228-33. Nesslinger NJ, Shi XB, deVere White RW. PMID: 12727844.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    132. Is bladder biopsy necessary at three or six months post BCG therapy? Urol Oncol. 2003 May-Jun; 21(3):207-9. Highshaw RA, Tanaka ST, Evans CP, deVere White RW. PMID: 12810207.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    133. BCL2 antisense reduces prostate cancer cell survival following irradiation. Cancer Biother Radiopharm. 2002 Dec; 17(6):647-56. Scott SL, Higdon R, Beckett L, Shi XB, deVere White RW, Earle JD, Gumerlock PH. PMID: 12537668.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    134. Application of a yeast assay to detect functional p53 mutations in archival prostate cancer tissue. Cancer Biother Radiopharm. 2002 Dec; 17(6):657-64. Shi XB, Di Mauro SM, Highshaw R, Deitch AD, Evans CP, Gumerlock PH, deVere White RW. PMID: 12537669.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    135. Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109. J Urol. 2002 Nov; 168(5):2016-9. Powell IJ, Tangen CM, Miller GJ, Lowe BA, Haas G, Carroll PR, Osswald MB, DeVERE WHITE R, Thompson IM, Crawford ED. PMID: 12394698.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    136. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology. 2002 Oct; 60(4):640-4. deVere White RW, Hackman RM, Soares SE, Beckett LA, Sun B. PMID: 12385925.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCTClinical Trials
    137. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? Cancer. 2002 Sep 01; 95(5):1009-15. Gandour-Edwards R, Lara PN, Folkins AK, LaSalle JM, Beckett L, Li Y, Meyers FJ, DeVere-White R. PMID: 12209684.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    138. Complex functions of mutant p53 alleles from human prostate cancer. Prostate. 2002 Apr 01; 51(1):59-72. Shi XB, Nesslinger NJ, Deitch AD, Gumerlock PH, deVere White RW. PMID: 11920959.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    139. Functional analysis of 44 mutant androgen receptors from human prostate cancer. Cancer Res. 2002 Mar 01; 62(5):1496-502. Shi XB, Ma AH, Xia L, Kung HJ, de Vere White RW. PMID: 11888926.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    140. Can single dose preoperative intrathecal morphine sulfate provide cost-effective postoperative analgesia and patient satisfaction during radical prostatectomy in the current era of cost containment? Prostate Cancer Prostatic Dis. 2002; 5(3):226-30. Eandi JA, de Vere White RW, Tunuguntla HS, Bohringer CH, Evans CP. PMID: 12496986.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    141. BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents. Cancer Biother Radiopharm. 2001 Oct; 16(5):421-9. Shi XB, Gumerlock PH, Muenzer JT, deVere White RW. PMID: 11776759.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    142. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization. Cancer J. 2001 Sep-Oct; 7(5):395-403. Liu HL, Gandour-Edwards R, Lara PN, de Vere White R, LaSalle JM. PMID: 11693898.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    143. Differences in gene expression in muscle-invasive bladder cancer: a comparison of Italian and American patients. Eur Urol. 2001 Apr; 39(4):430-7. Williams SG, Gandour-Edwards R, Deitch AD, Toscano S, Fan JJ, Sternberg CN, Pansadoro V, Calabrò F, Rossetti A, deVere White RW. PMID: 11306882.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    144. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results. Am J Clin Oncol. 2000 Aug; 23(4):330-3. Wilder RB, Chou RH, Ryu JK, Stern RL, Wong MS, Ji M, Roach M, White RD. PMID: 10955856.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    145. Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology. 2000 Jun; 55(6):800-6. Dow JK, deVere White RW. PMID: 10840080.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    146. Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor. AJR Am J Roentgenol. 2000 Jun; 174(6):1592-4. Hall WH, McGahan JP, Link DP, deVere White RW. PMID: 10845488.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    147. The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group Study. Eur Urol. 2000 May; 37(5):595-600. deVere White RW, Deitch AD, Daneshmand S, Blumenstein B, Lowe BA, Sagalowsky AI, Smith JA, Schellhammer PF, Stanisic TH, Grossman HB, Messing E, Crissman JD, Crawford ED. PMID: 10765099.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    148. Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy. Am J Clin Oncol. 2000 Apr; 23(2):176-80. Wilder RB, Hsiang JY, Ji M, Earle JD, de Vere White R. PMID: 10776980.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    149. Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation. Urology. 2000 Apr; 55(4):521-5. Edelman MJ, Meyers FJ, Miller TR, Williams SG, Gandour-Edwards R, deVere White RW. PMID: 10736495.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    150. Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy. Int J Radiat Oncol Biol Phys. 2000 Apr 01; 47(1):115-9. Chou RH, Wilder RB, Ji M, Ryu JK, Leigh BR, Earle JD, Doggett RL, Kubo HD, Roach M, deVere White RW. PMID: 10758312.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    151. Present and future management of prostate cancer. Cancer Biother Radiopharm. 2000 Apr; 15(2):121-5. de Vere White R. PMID: 10803316.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    152. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology. 1999 Oct; 54(4):662-9. Roehrborn CG, Boyle P, Bergner D, Gray T, Gittelman M, Shown T, Melman A, Bracken RB, deVere White R, Taylor A, Wang D, Waldstreicher J. PMID: 10510925.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    153. Use of a yeast assay to detect functional alterations in p53 in prostate cancer: review and future directions. Prostate. 1999 Oct 01; 41(2):134-42. deVere White RW, Deitch AD, Gumerlock PH, Shi XB. PMID: 10477910.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    154. Future prospects in prostate cancer. Prostate. 1999 Sep 01; 40(4):261-8. Hegarty NJ, Fitzpatrick JM, Richie JP, Scardino PT, deVere White RW, Schröder FH, Coffey DS. PMID: 10420155.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    155. Immunohistochemical analysis of BCL-2 protein expression in renal cell carcinoma. J Urol. 1999 Aug; 162(2):610-3. Huang A, Fone PD, Gandour-Edwards R, White RW, Low RK. PMID: 10411096.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    156. Overexpression of cyclin D1 is rare in human prostate carcinoma. Prostate. 1999 Jan 01; 38(1):40-5. Gumbiner LM, Gumerlock PH, Mack PC, Chi SG, deVere White RW, Mohler JL, Pretlow TG, Tricoli JV. PMID: 9973108.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    157. Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors. Cancer. 1998 Dec 15; 83(12):2534-9. Meyers FJ, Gumerlock PH, Chi SG, Borchers H, Deitch AD, deVere White RW. PMID: 9874460.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    158. Predicting prognosis in patients with superficial bladder cancer. Oncology (Williston Park). 1998 Dec; 12(12):1717-23; discussion 1724-6. de Vere White RW, Stapp E. PMID: 9874845.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    159. Racial differences in clinically localized prostate cancers of black and white men. J Urol. 1998 Jun; 159(6):1979-82; discussion 1982-3. deVere White RW, Deitch AD, Jackson AG, Gandour-Edwards R, Marshalleck J, Soares SE, Toscano SN, Lunetta JM, Stewart SL. PMID: 9598502.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    160. Prostate carcinoma: clarification through clinical insight and molecular diagnostics. West J Med. 1998 Jun; 168(6):525. Meyers FJ, DeVere White RW. PMID: 9655997.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    161. p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy. Urology. 1998 Feb; 51(2):346-51. Huang A, Gandour-Edwards R, Rosenthal SA, Siders DB, Deitch AD, White RW. PMID: 9495727.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    162. Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade. Prostate. 1998 Feb 01; 34(2):145-51. Mack PC, Chi SG, Meyers FJ, Stewart SL, deVere White RW, Gumerlock PH. PMID: 9465946.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    163. Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group. Urology. 1997 Dec; 50(6):882-7. Ellis WJ, Blumenstein BA, Ishak LM, Enfield DL. PMID: 9426718.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    164. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas. Clin Cancer Res. 1997 Oct; 3(10):1889-97. Chi SG, deVere White RW, Muenzer JT, Gumerlock PH. PMID: 9815578.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    165. Improved detection of recurrent bladder cancer using the Bard BTA stat Test. Urology. 1997 Sep; 50(3):349-53. Sarosdy MF, Hudson MA, Ellis WJ, Soloway MS, deVere White R, Sheinfeld J, Jarowenko MV, Schellhammer PF, Schervish EW, Patel JV, Chodak GW, Lamm DL, Johnson RD, Henderson M, Adams G, Blumenstein BA, Thoelke KR, Pfalzgraf RD, Murchison HA, Brunelle SL. PMID: 9301696.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    166. Localization of the prostatic apex for radiotherapy treatment planning using urethroscopy. Int J Radiat Oncol Biol Phys. 1997 Jul 01; 38(4):737-41. Wilder RB, Fone PD, Rademacher DE, Jones CD, Roach M, Earle JD, White RD. PMID: 9240640.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    167. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol. 1997 Apr; 11(4):450-9. Tan J, Sharief Y, Hamil KG, Gregory CW, Zang DY, Sar M, Gumerlock PH, deVere White RW, Pretlow TG, Harris SE, Wilson EM, Mohler JL, French FS. PMID: 9092797.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansAnimalsCells
    168. Human androgen receptor expression in prostate cancer following androgen ablation. Eur Urol. 1997; 31(1):1-6. de Vere White R, Meyers F, Chi SG, Chamberlain S, Siders D, Lee F, Stewart S, Gumerlock PH. PMID: 9032526.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    169. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network. J Natl Cancer Inst. 1997 Jan 01; 89(1):66-71. Gumerlock PH, Chi SG, Shi XB, Voeller HJ, Jacobson JW, Gelmann EP, deVere White RW. PMID: 8978408.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    170. Post-prostatectomy incontinence and the artificial urinary sphincter: a long-term study of patient satisfaction and criteria for success. J Urol. 1996 Dec; 156(6):1975-80. Litwiller SE, Kim KB, Fone PD, White RW, Stone AR. PMID: 8911369.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    171. Identification of p53 mutations in archival prostate tumors. Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assay. Diagn Mol Pathol. 1996 Dec; 5(4):271-8. Shi XB, Bodner SM, deVere White RW, Gumerlock PH. PMID: 8955619.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    172. CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res. 1996 Jul 01; 56(13):3042-6. Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, Schwartz S, Kung HJ, de Vere White RW, Gumerlock PH, Resnick MI, Amini SB, Pretlow TG. PMID: 8674060.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    173. Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues. Hum Pathol. 1996 Jun; 27(6):573-80. Wertz IE, Deitch AD, Gumerlock PH, Gandour-Edwards R, Chi SG, de Vere White RW. PMID: 8666367.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    174. NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas. J Urol. 1996 Jun; 155(6):2080-4. Borchers H, Meyers FJ, Gumerlock PH, Stewart SL, deVere White RW. PMID: 8618340.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    175. Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder. J Urol. 1996 May; 155(5):1754-7. Glick SH, Howell LP, White RW. PMID: 8627878.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    176. Alterations of the retinoblastoma gene in human prostate adenocarcinoma. Genes Chromosomes Cancer. 1996 Feb; 15(2):108-14. Tricoli JV, Gumerlock PH, Yao JL, Chi SG, D'Souza SA, Nestok BR, deVere White RW. PMID: 8834174.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    177. Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group study. Urol Oncol. 1996 Jan-Feb; 2(1):27-34. Devere White RW, Deitch AD, Tesluk H, Blumensteinj B, Lowe BA, Sagalowsky AI, Smith JA, Schellhammer PF, Stanisic TH, Grossman HB, Messing E, Crissman JD, Crawford ED. PMID: 21224132.
      View in: PubMed   Mentions: 1     Fields:    
    178. Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression. Cancer Res. 1995 Dec 01; 55(23 Suppl):5837s-5841s. DeNardo SJ, Gumerlock PH, Winthrop MD, Mack PC, Chi SG, Lamborn KR, Shen S, Miers LA, deVere White RW, DeNardo GL. PMID: 7493356.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    179. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol. 1995 Aug; 154(2 Pt 1):379-83; discussion 383-4. Sarosdy MF, deVere White RW, Soloway MS, Sheinfeld J, Hudson MA, Schellhammer PF, Jarowenko MV, Adams G, Blumenstein BA. PMID: 7609102.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    180. Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma. J Urol. 1995 Mar; 153(3 Pt 2):1041-2. Huang A, Low RK, deVere White R. PMID: 7853555.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    181. Quantitation of NM23 expression in human prostate tissues. J Urol. 1994 Jul; 152(1):202-7. Fishman JR, Gumerlock PH, Meyers FJ, deVere White RW. PMID: 7515452.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    182. p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst. 1994 Jun 15; 86(12):926-33. Chi SG, deVere White RW, Meyers FJ, Siders DB, Lee F, Gumerlock PH. PMID: 7515114.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    183. p53 mutations in benign prostatic hyperplasia. J Natl Cancer Inst. 1993 Nov 17; 85(22):1856-8. Meyers FJ, Chi SG, Fishman JR, deVere White RW, Gumerlock PH. PMID: 7693956.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    184. False DNA aneuploidy in canine and human neoplasms. Anticancer Res. 1993 Nov-Dec; 13(6A):2117-8. Deitch AD, de Vere White RW, Madewell BR. PMID: 8297122.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    185. Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue. Cancer. 1993 Sep 01; 72(5):1692-700. Deitch AD, Miller GJ, deVere White RW. PMID: 7688657.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    186. Color flow sonographic mapping of intravascular extension of malignant renal tumors. J Ultrasound Med. 1993 Jul; 12(7):403-9. McGahan JP, Blake LC, deVere White R, Gerscovich EO, Brant WE. PMID: 8394940.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    187. Surgery of renal cell carcinoma. Urol Clin North Am. 1993 May; 20(2):263-75. Couillard DR, deVere White RW. PMID: 8493749.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    188. Fixation method useful for cytologic examination and DNA flow cytometry of exfoliated bladder cells. Urology. 1993 May; 41(5):472-5. Howell LP, Deitch AD, Andreotti VA, Westrick LA, White RD. PMID: 7683835.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    189. Tuberculous spondylitis as a complication of intravesical bacillus Calmette-Guerin therapy. J Urol. 1993 Mar; 149(3):584-7. Fishman JR, Walton DT, Flynn NM, Benson DR, deVere White RW. PMID: 8437271.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    190. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference. Cytometry. 1993; 14(5):478-81. Wheeless LL, Badalament RA, de Vere White RW, Fradet Y, Tribukait B. PMID: 8354118.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    191. Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma. J Urol. 1993 Jan; 149(1):42-5. Amberson JB, Laino JP. PMID: 8417214.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    192. Prognostic significance of mucosal aneuploidy in stage Ta/T1 grade 3 carcinoma of the bladder. J Urol. 1992 Nov; 148(5):1420-6; discussion 1426-7. Norming U, Tribukait B, Nyman CR, Nilsson B, Wang N. PMID: 1433541.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    193. Deoxyribonucleic acid cytometry and histological findings before and after 125iodine implantation of primary prostate cancer. J Urol. 1992 Sep; 148(3):838-41; discussion 841-2. Waehre H, Amellem O, Stenwig AE, Tverå K, Juul M, Pettersen EO, Fosså SD. PMID: 1512835.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    194. -Y,-1 as recurrent anomaly in oncocytoma. Cancer Genet Cytogenet. 1992 Jul 01; 61(1):108-9. Meloni AM, Sandberg AA, White RD. PMID: 1638476.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    195. Flow cytometry as a predictive modality in prostate cancer. Hum Pathol. 1992 Apr; 23(4):352-9. Deitch AD, deVere White RW. PMID: 1563735.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    196. Urinary prostate specific antigen levels: role in monitoring the response of prostate cancer to therapy. J Urol. 1992 Mar; 147(3 Pt 2):947-51. DeVere White RW, Meyers FJ, Soares SE, Miller DG, Soriano TF. PMID: 1371566.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    197. Evaluation of DNA flow cytometry as a screening test for bladder cancer. J Cell Biochem Suppl. 1992; 16I:80-4. deVere White RW, Deitch AD. PMID: 1305694.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    198. Intervention strategies for chemoprevention of bladder cancer. J Cell Biochem Suppl. 1992; 16I:173-4. Sheinfeld J, Herr HW. PMID: 1305683.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    199. The hemodynamics of vacuum constriction erections: assessment by color Doppler ultrasound. J Urol. 1992 Jan; 147(1):57-61. Broderick GA, McGahan JP, Stone AR, White RD. PMID: 1729552.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    200. Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction. Cancer. 1991 Apr 15; 67(8):2087-95. Meyers FJ, Gumerlock PH, Kawasaki ES, Wang AM, deVere White RW, Erlich HA. PMID: 2004327.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    201. Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res. 1991 Mar 15; 51(6):1632-7. Gumerlock PH, Poonamallee UR, Meyers FJ, deVere White RW. PMID: 1998954.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    202. DNA flow cytometric study of the hyperplastic and neoplastic canine prostate. Prostate. 1991; 18(2):173-9. Madewell BR, Deitch AD, Higgins RJ, Marks SL, deVere White RW. PMID: 1706513.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    203. Precision of DNA flow cytometry in inter-institutional analyses. Cytometry. 1991; 12(5):405-12. Wheeless LL, Coon JS, Cox C, Deitch AD, deVere White RW, Fradet Y, Koss LG, Melamed MR, O'Connell MJ, Reeder JE. PMID: 1935456.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    204. Neobladders: clinical management and considerations for patients receiving chemotherapy. Semin Oncol. 1990 Oct; 17(5):598-605. Broderick GA, Stone AR, deVere White R. PMID: 2218572.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    205. Evaluation of DNA flow cytometry as a screening test for bladder cancer. J Occup Med. 1990 Sep; 32(9):898-903. Deitch AD, Anderson KA, deVere White RW. PMID: 2074516.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    206. Neoadjuvant therapy of carcinoma of the bladder. Semin Urol. 1990 Aug; 8(3):197-200. deVere White RW. PMID: 2204981.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    207. A clinically applicable method to preserve urine and bladder washing cells for flow cytometric monitoring of bladder cancer patients. J Urol. 1990 Apr; 143(4):700-5. Deitch AD, Andreotti VA, Strand MA, Howell L, deVere White RW. PMID: 2179581.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    208. Comparison of flow cytometry to routine testicular biopsy in male infertility. Urology. 1990 Apr; 35(4):321-6. Hellstrom WJ, Tesluk H, Deitch AD, de Vere White RW. PMID: 2321325.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    209. Prognosis in disseminated prostate cancer as related to tumor ploidy and differentiation. World Journal of Urology. 1990 Mar 1; 8(1):47-50. Ralph W. deVere White, Arline D. Deitch, Henry Tesluk, Kathleen R. Lamborn, Frederick J. Meyers. .
      View in: Publisher Site   Mentions:
    210. In situ renal perfusion. World Journal of Urology. 1990 Mar 1; 8(1):55-57. Susan L. Timmons, Richard Ward, Ralph W. deVere White. .
      View in: Publisher Site   Mentions:
    211. Aspiration biopsy cytology of the prostate in young adult men. Diagn Cytopathol. 1990; 6(2):89-94. Howell LP, Amott TR, deVere-White R. PMID: 2338041.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    212. Sequential flow cytometry and single gene analysis by enzymatic amplification and allele specific oligonucleotide hybridization of urothelial cells. J Urol. 1989 Dec; 142(6):1599-601. Meyers FJ, Gumerlock PH, Teplitz RL, Hatcher SL, deVere White RW. PMID: 2585644.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    213. Measurement variability in DNA flow cytometry of replicate samples. Cytometry. 1989 Nov; 10(6):731-8. Wheeless LL, Coon JS, Cox C, Deitch AD, de Vere White RW, Koss LG, Melamed MR, O'Connell MJ, Reeder JE, Weinstein RS. PMID: 2582964.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    214. Deoxyribonucleic acid flow cytometry of benign prostatic disease. J Urol. 1989 Sep; 142(3):759-62. Deitch AD, Strand MA, de Vere White RW. PMID: 2769856.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    215. Treatment and complications of Fournier's gangrene. Br J Urol. 1989 Sep; 64(3):310-4. Wolach MD, MacDermott JP, Stone AR, deVere White RW. PMID: 2804566.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    216. The clinical application of aspiration deoxyribonucleic acid flow cytometry to neurologically impaired men entering an electroejaculation program. J Urol. 1989 Aug; 142(2 Pt 1):309-12. Hellstrom WJ, Stone AR, Deitch AD, deVere White RW. PMID: 2787410.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    217. RAS enzyme-linked immunoblot assay discriminates p21 species: a technique to dissect gene family expression. Anal Biochem. 1989 Jul; 180(1):158-68. Gumerlock PH, Meyers FJ, Kokoris SP, Wong G, McCormick FP, de Vere White RW. PMID: 2683857.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    218. Human bladder and colon carcinomas contain activated ras p21. Specific detection of twelfth codon mutants. Cancer. 1989 Jun 01; 63(11):2177-81. Meyers FJ, Gumerlock PH, Kokoris SP, deVere White RW, McCormick F. PMID: 2655864.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    219. GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis. J Clin Oncol. 1989 Jun; 7(6):700-5. Hesketh PJ, Murphy WK, Lester EP, Gandara DR, Khojasteh A, Tapazoglou E, Sartiano GP, White DR, Werner K, Chubb JM. PMID: 2523957.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    220. Ethanol fixation of bladder irrigation specimens for flow cytometric analysis. A multiinstitutional study from the bladder cancer flow cytometry network. Cancer. 1989 May 01; 63(9):1780-3. Hermansen DK, Melamed MR, Coon JS, Weinstein RS, White RD, Deitch AD, Wheeless LL, Reeder JE, Wersto R, Koss LG. PMID: 2702585.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    221. Check samples for laboratory self-assessment in DNA flow cytometry. The National Cancer Institute's Flow Cytometry Network experience. Cancer. 1989 Apr 15; 63(8):1592-9. Coon JS, Deitch AD, de Vere White RW, Koss LG, Melamed MR, Reeder JE, Weinstein RS, Wersto RP, Wheeless LL. PMID: 2924266.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    222. Evaluation of vasovasostomy candidates by deoxyribonucleic acid flow cytometry of testicular aspirates. Fertil Steril. 1989 Mar; 51(3):546-8. Hellstrom WJ, Deitch AD, deVere White RW. PMID: 2920857.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    223. Flow cytometry study of cytokeratin 18 expression according to tumor grade and deoxyribonucleic acid content in human bladder tumors. J Urol. 1989 Mar; 141(3):522-6. Hijazi A, Devonec M, Bouvier R, Revillard JP. PMID: 2465418.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    224. Activated c-N-ras in radiation-induced acute nonlymphocytic leukemia: twelfth codon aspartic acid. Radiat Res. 1989 Feb; 117(2):198-206. Gumerlock PH, Meyers FJ, Foster BA, Kawakami TG, deVere White RW. PMID: 2646654.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    225. Development of monoclonal antibody imaging of metastatic prostatic carcinoma. Prostate. 1989; 14(3):209-20. Meyers FJ, Denardo SJ, Macey D, White RD, Unger M. PMID: 2471962.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    226. Comparison of automated and manual techniques for analysis of DNA frequency distributions in bladder washings. Cytometry. 1988 Nov; 9(6):600-4. Wheeless LL, Coon JS, Deitch AD, deVere White RW, Koss LG, Melamed MR, Reeder JE, Robinson RD, Weinstein RS, Wersto RP. PMID: 3208625.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    227. Quantitative analysis of keratin 18 in the urine of patients with bladder cancer. J Urol. 1988 Aug; 140(2):436-9. Baker WC, deVere White R, Rossitto PV, Min BH, Cardiff RD. PMID: 2456406.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    228. Characterization of urinary keratin number 18 using a new assay. J Urol. 1988 Aug; 140(2):431-5. Rossitto PV, Chan R, Strand MA, Miller CH, Baker WC, Deitch AD, deVere White R, Cardiff RD. PMID: 2456405.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    229. Urine: a suitable sample for deoxyribonucleic acid flow cytometry studies in patients with bladder cancer. J Urol. 1988 May; 139(5):926-8. deVere White RW, Deitch AD, Baker WC, Strand MA. PMID: 3361665.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    230. Pseudomyxoma peritonei presenting as a scrotal mass. J Urol. 1988 Apr; 139(4):821-2. Baker WC, Goldman LB, deVere White RW. PMID: 3352057.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    231. The limited usefulness of external beam radiotherapy in the control of superficial bladder cancer. Br J Urol. 1988 Apr; 61(4):330-2. Sawczuk IS, Olsson CA, deVere White R. PMID: 3382886.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    232. Prostatic-specific antigen: clinical experience utilizing immunoperoxidase staining techniques in patients with metastatic prostate cancer. J Surg Oncol. 1988 Mar; 37(3):165-7. Baker WC, Meyers FJ, White RW. PMID: 2451087.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    233. The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer. J Urol. 1988 Feb; 139(2):279-82. deVere White RW, Deitch AD, West B, Fitzpatrick JM. PMID: 3339725.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    234. Misleading testicular masses. Urology. 1988 Feb; 31(2):111-3. Baker WC, Bishai MB, DeVere White RW. PMID: 3277324.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    235. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer. Urology. 1987 Oct; 30(4):357-8. Baker WC, Russo MA, deVere White RW. PMID: 3116739.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    236. Filarial chyluria as a cause of acute urinary retention. Urology. 1987 Jun; 29(6):642-5. Sherman RH, Goldman LB, deVere White RW. PMID: 3576897.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    237. Flow cytometric analysis of testicular tissue: Detection of injury and recovery. World Journal of Urology. 1986 Sep 1; 4(2):71-76. Arline D. Deitch, Susan D. Goldberg, Ralph W. deVere White. .
      View in: Publisher Site   Mentions:
    238. Flow cytometry: role in monitoring transitional cell carcinoma of bladder. Urology. 1986 Jul; 28(1):15-20. deVere White RW, Olsson CA, Deitch AD. PMID: 3727223.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    239. Post urethroplasty squamous cell carcinoma. N Y State J Med. 1986 May; 86(5):261-3. Sawczuk I, Acosta R, Grant D, White RD. PMID: 3459083.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    240. CT findings in Addison's disease caused by tuberculosis. Urol Radiol. 1986; 8(1):44-5. Sawczuk IS, Reitelman C, Libby C, Grant D, Vita J, White RD. PMID: 3727207.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    241. Predicting the invasive potential of bladder carcinoma. World Journal of Urology. 1985 Sep 1; 3(2):73-75. Ralph W. deVere White, Alden G. Cockburn. .
      View in: Publisher Site   Mentions:
    242. Varicocele: temporal considerations. J Urol. 1985 Aug; 134(2):411-3. Nagler HM, Li XZ, Lizza EF, Deitch A, White RD. PMID: 4020998.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    243. Relationship between thiol depletion and chemosensitization in a transplantable murine bladder tumor. J Natl Cancer Inst. 1985 Jun; 74(6):1233-8. Tomashefsky P, Astor M, White RD. PMID: 3858595.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    244. The role of flow cytometry in urologic disease. Semin Urol. 1985 May; 3(2):132-45. deVere White RW, Deitch AD. PMID: 3916558.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    245. Primary transitional cell carcinoma of prostatic periurethral ducts. Urology. 1985 Apr; 25(4):339-43. Sawczuk I, Tannenbaum M, Olsson CA, deVere White R. PMID: 3885546.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    246. The influence of cytoreductive surgery on the response to chemotherapy of a rat renal cancer. Urol Res. 1985; 13(1):35-8. deVere White R, Deitch AD, Hong WK, Olsson CA. PMID: 3992765.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    247. Comparison of histologic and flow cytometric evaluation of cyclophosphamide-induced testicular damage. Urology. 1984 Nov; 24(5):472-5. Goldberg SD, Deitch AD, Schevchuck M, Nagler HM, deVere White R. PMID: 6495459.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    248. Nonsurgical management of patients with stage D1 adenocarcinoma of prostate: risks vs benefits. Urology. 1984 Nov; 24(5 Suppl):12-5. deVere White R. PMID: 6541825.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    249. Testicular torsion: temporal considerations. Fertil Steril. 1984 Aug; 42(2):257-62. Nagler HM, Deitch AD, deVere White R. PMID: 6745459.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    250. Alterations of physical and biochemical parameters of the R3327-CP rat prostate adenocarcinoma following hormonal manipulation of the host. J Urol. 1984 Jun; 131(6):1218-24. Buttyan R, Tomashefsky P, Deitch AD, Olsson CA, Devere-White R. PMID: 6726931.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    251. Familial idiopathic priapism: a case report. J Urol. 1984 Mar; 131(3):542-3. Nagler HM, deVere White R, Roberts M. PMID: 6700001.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    252. Misonidazole as a chemosensitizer in the treatment of the Dunning prostate cancer model. J Urol. 1984 Feb; 131(2):374-7. White RD, Romas NA, Tomashefsky P, Hall EJ, Olsson CA. PMID: 6699977.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    253. The impact of lymphnode metastases in renal adenocarcinoma: prognostic impact and effect of lymphadenectomy. Prog Clin Biol Res. 1984; 153:437-9. deVere White R. PMID: 6473406.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    254. The effect of delta 1-testolactone on serum testosterone and estradiol in the adult male rat. Fertil Steril. 1983 Dec; 40(6):818-22. Nagler HM, deVere White R, Dyrenfurth I, Hembree WC. PMID: 6653801.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    255. Radiation and chemotherapy for stage D1 prostate cancer. Semin Urol. 1983 Nov; 1(4):261-8. deVere White R. PMID: 6399612.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    256. Adjuvant chemotherapy for stage D1 adenocarcinoma of prostate. Urology. 1983 Mar; 21(3):270-2. deVere White R, Babayan RK, Krikorian J, Krane RJ, Olsson CA. PMID: 6836806.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    257. Limitations of DNA histogram analysis by flow cytometry as a method of predicting chemosensitivity in a rat renal cancer model. Cancer Res. 1983 Feb; 43(2):604-10. deVere White R, Deitch AD, Olsson CA. PMID: 6293701.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    258. Maytansine as a cause of acute proliferative disorder of bladder urothelium in the rat. Cancer Treat Rep. 1983 Feb; 67(2):183-4. deVere White R, O'Brien M, Krikorian J, Babayan R, Olsson CA. PMID: 6825127.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    259. Keyhole-limpet haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma. Urol Res. 1983; 11(6):263-5. Walsh WG, Tomashefsky P, Olsson CA, deVere White R. PMID: 6659223.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    260. Sensitivity of computed tomography in evaluation of pelvic lymph node metastases from carcinoma of bladder and prostate. Urology. 1983 Jan; 21(1):81-4. Sawczuk IS, deVere White R, Gold RP, Olsson CA. PMID: 6823714.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    261. The effect of testicular torsion on the contralateral testis. J Urol. 1982 Dec; 128(6):1343-8. Nagler HM, White RD. PMID: 7154207.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    262. Errors in measurement and reporting of serum markers in patients with germ cell tumors. Urology. 1982 Nov; 20(5):476-8. Kardon FM, Krikorian JG, Lopez JA, White RD. PMID: 6183813.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    263. A stable propidium iodide staining procedure for flow cytometry. J Histochem Cytochem. 1982 Sep; 30(9):967-72. Deitch AD, Law H, deVere White R. PMID: 6182188.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    264. Chemosensitivity of murine renal carcinoma. Urol Res. 1982 Feb; 10(1):27-30. de Vere White R, Ki Hong W, Tannenbaum M, Olsson CA. PMID: 7200273.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    265. Testis tumor markers: how accurate are they? J Urol. 1981 May; 125(5):661-3. deVere White R, Karian S, Hong WK, Olsson CA. PMID: 6164799.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    266. Renal adenocarcinoma in the rat: a new tumor model. Invest Urol. 1980 Mar; 17(5):405-12. White RV, Olsson DA. PMID: 7358504.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    267. Occupational lead exposure, nephropathy, and renal cancer. Am J Ind Med. 1980; 1(2):139-48. Baker EL, Goyer RA, Fowler BA, Khettry U, Bernard DB, Adler S, White RD, Babayan R, Feldman RG. PMID: 7342761.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    268. Benefits and complications of staging pelvic lymph node dissection in prostatic adenocarcinoma. Prostate. 1980; 1(3):345-9. Babayan RK, White RD, Austen G, Krane RJ, Feldman M, Olsson CA. PMID: 7279804.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    269. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors. Prog Clin Biol Res. 1979; 33:209-21. Olsson CA, deVere White R, Goldstein I, Traish AM, Müller RE, Wotiz HH. PMID: 93750.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    270. Trimethoprium-sulfamethoxazole and minocycline- hydrochloride in the treatment of culture-proved bacterial prostatitis. J Urol. 1978 Aug; 120(2):184-5. Paulson DF, White RD. PMID: 671629.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    271. Staging profile of hypofertile male subjects. J Urol. 1978 Jul; 120(1):71-2. White RD, Paulson DF. PMID: 671611.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    272. A new animal model for testing the effectiveness of chemotherapeutic agents on renal adenocarcinoma. Surg Forum. 1978; 29:629-31. White RD, Previte S, Olsson CA. PMID: 401284.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    273. Case profile: unusual complications of radical perineal prostatectomy. Urology. 1978 Jan; 11(1):95. White RD, Cleeve L, Weinerth J. PMID: 414404.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    274. Obstruction of the male reproductive tract. J Urol. 1977 Aug; 118(2):266-8. White RD, Paulson DF. PMID: 894804.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    275. Renal cyst puncture and abscess formation. Urology. 1977 Aug; 10(2):98-9. Lockhart JL, Wacksman J, White RD, Older RA, Jackson DC, Johnsrude IS, Glenn JF. PMID: 898464.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    276. Clomiphene citrate: pharmacologic treatment of hypofertile male. Urology. 1977 Apr; 9(4):419-21. Paulson DF, Hammond CB, de Vere White R, Wiebe RH. PMID: 855067.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    277. The clinical spectrum of prostate cancer. J Urol. 1977 Mar; 117(3):323-7. de Vere White R, Paulson DF, Glenn JF. PMID: 839594.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    278. Bilateral renal carcinoma in von Hippel-Lindau Disease. Urology. 1976 Nov; 8(5):475-8. Mullin EM, White RD, Peterson LJ, Paulson DF. PMID: 982734.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    279. Review of thirty total cystectomys. Ir Med J. 1975 Feb 22; 68(4):90-2. de Vere White R, Kelly DG, Duff F. PMID: 1112693.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    280. A review of 200 cases of bladder tumour. J Ir Med Assoc. 1973 Dec 22; 66(24):711-5. De Vere White R, Kelly D, Duff F. PMID: 4776027.
      View in: PubMed   Mentions:    Fields:    Translation:Humans